84846-34-4 Usage
General Description
2-Pyrrolidinecarboxamide, 4-hydroxy-N-phenyl-, (2S,4R)- is a chemical compound with a stereoisomeric structure that belongs to the class of pyrrolidinecarboxamides. It has a 4-hydroxyphenyl group attached to the pyrrolidine ring, and the stereochemistry of the compound is (2S,4R). 2-Pyrrolidinecarboxamide, 4-hydroxy-N-phenyl-, (2S,4R)- is known for its potential pharmacological activities, including its antioxidant and anti-inflammatory properties. It may also have applications in the field of pharmaceuticals and drug discovery due to its unique structure and biological activities. Additional research is needed to further explore the potential benefits and applications of this compound.
Check Digit Verification of cas no
The CAS Registry Mumber 84846-34-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,4,8,4 and 6 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 84846-34:
(7*8)+(6*4)+(5*8)+(4*4)+(3*6)+(2*3)+(1*4)=164
164 % 10 = 4
So 84846-34-4 is a valid CAS Registry Number.
84846-34-4Relevant articles and documents
Enantioselective organocatalytic Biginelli reaction: Dependence of the catalyst on sterics, hydrogen bonding, and reinforced chirality
Saha, Satyajit,Moorthy, Jarugu Narasimha
supporting information; experimental part, p. 396 - 402 (2011/04/17)
From a systematic investigation involving the synthesis of a series of catalysts and screening studies, the organocatalyst 16, which is sterically hindered, contains a strong hydrogen-bonding site, and is endowed with reinforced chirality, is shown to pro
An enantioselective Biginelli reaction catalyzed by a simple chiral secondary amine and achiral Bronsted acid by a dual-activation route
Xin, Junguo,Chang, Lu,Hou, Zongrui,Shang, Deju,Liu, Xiaohua,Feng, Xiaoming
supporting information; experimental part, p. 3177 - 3181 (2009/04/11)
An enantioselective Biginelli reaction that proceeds by a dual-activation route has been developed by using a combined catalyst of a readily available trans-4-hydroxyproline-derived secondary amine and a Bronsted acid. Aromatic, heteroaromatic, and fusedr
